18:33 10.12.2020
Head of the Executive Board, Darnitsa Group: COVID-19 pandemic has proven that a strong pharmaceutical industry strengthens national security 13 min read
In an interview with the “Interfax – Ukraine News Agency” Darnitsa Group Executive Board Head Dmytro Shymkiv talked about the 2020 results, perspectives of Ukraine’s return to production of vaccines, innovative drugs, and about the competition at the pharmaceuticals market
By Anna Levchenko
- Can the Ukrainian pharmaceutical manufactures produce the COVID-19 vaccine?
- There are about thirty candidate vaccines that are currently in phase II or III of clinical studies. This means studies of those vaccines are entering the final straight. Three of them are famous vaccines by Moderna, Pfizer, and AstraZeneca. We are most likely to see the results of work of those three companies in the form of the approved vaccine approximately by the beginning of 2021.